High-intensity exercise has a beneficial effect on fatigue and improves quality of life in patients with rheumatoid arthritis ...
Novartis will launch a direct-to-patient (DTP) platform in the US on November 1, 2025, starting with Cosentyx, which will be offered at a 55% dis ...